Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2010
06/01/2010CA2157427C Oxazoloquinolinone derivatives, their preparation and their therapeutic application
05/2010
05/27/2010WO2010060037A2 Adamantane modulators of nmda receptor and/or 5ht3 receptor
05/27/2010WO2010059858A1 Manassantin compounds and methods of making and using same
05/27/2010WO2010059836A1 Substituted aza-bridged bicyclics for cardiovascular and cns disease
05/27/2010WO2010059773A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
05/27/2010WO2010059610A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine compounds useful as faah modulators and uses thereof
05/27/2010WO2010059436A1 Early treatment and prevention of increased muscle tonicity
05/27/2010WO2010059390A1 Modulators of serotonin receptor
05/27/2010WO2010059242A2 Neurodegenerative disease diagnostic compositions and methods of use
05/27/2010WO2010059241A2 Treatment of amyotrophic lateral sclerosis
05/27/2010WO2010058926A2 Pharmaceutical composition containing ginger extract or shogaol
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058794A1 Antioxidant
05/27/2010WO2010058517A1 NERVE CELL STIMULATOR COMPRISING IgG AND/OR Fc FRAGMENT OF IgG
05/27/2010WO2010058512A1 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives
05/27/2010WO2010058414A1 Novel pyrroiol2,l-cu1.41benzodiazepine derivatives with dithiocarbamate side chains and process for the preparation thereof
05/27/2010WO2010058333A1 Lactams as beta secretase inhibitors
05/27/2010WO2010058060A1 Aryl piperazine and their use as alpha2c antagonists
05/27/2010WO2010058020A1 Novel 1 -alkyl- 3 -hydroxy- 3 -phenylazetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
05/27/2010WO2010058019A1 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
05/27/2010WO2010058018A1 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
05/27/2010WO2010058017A1 Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
05/27/2010WO2010057882A2 Composition for producing anti-amyloid beta peptide antibodies with d-peptides
05/27/2010WO2010057865A1 N- inden- 2 -yl- isopropylsulfonamides as ampa receptor potentiators
05/27/2010WO2010057848A1 8-azabicyclo [3.2.1]oct-2-ene derivatives and their use as mono-amine neurotransmitter re-uptake inhibitors
05/27/2010WO2010057795A1 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
05/27/2010WO2010057418A1 A phenoxypyrimidine derivative, its preparation method and the use thereof
05/27/2010WO2010057317A1 Liposomal composition for convection-enhanced delivery to the central nervous centre
05/27/2010WO2010057295A1 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
05/27/2010WO2010026110A3 6-substituted benzoxazines as 5-ht-5a receptor antagonists
05/27/2010WO2010025322A9 Magnetic nanodelivery of therapeutic agents across the blood brain barrier
05/27/2010WO2010019275A9 Compositions and methods for treatment during non-acute periods following cns neurological injury
05/27/2010WO2010018213A3 Spiroimidazole compounds suitable for the treatment of neurological disorders
05/27/2010WO2010017626A4 Compositions comprising terpene compounds for treating negative sensory phenomena
05/27/2010WO2010017272A3 Method of treating neurological diseases
05/27/2010WO2010000372A3 New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
05/27/2010WO2009153178A3 Aryl ketone as mri
05/27/2010WO2009140649A3 Rab3b for the treatment and prevention of parkinson's disease
05/27/2010WO2009057111A3 Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system
05/27/2010WO2009018367A3 Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-methoxypyridin)yl]-4-penten-2-amine
05/27/2010WO2008070780A9 Antagonist antibodies against ephb3
05/27/2010WO2006103261A9 Inhibitors of neurotrypsin and determination thereof
05/27/2010US20100132060 Therapeuting compositions comprising an rnai agent and a neurotrophic factor and methods of use thereof
05/27/2010US20100130619 Pharmaceutical composition for parenteral administration of idebenone
05/27/2010US20100130617 Ethanolamine modulators of nmda receptor and muscarinic acetylcholine receptor
05/27/2010US20100130611 Omega 3 fatty acid formulations
05/27/2010US20100130607 Neuroprotection in demyelinating diseases
05/27/2010US20100130594 Cns gene delivery using peripheral administration of aav vectors
05/27/2010US20100130583 Prolinamide derivatives as modulators of voltage-gated sodium channels
05/27/2010US20100130582 Indolinone modulators of dopamine receptor
05/27/2010US20100130577 Pyrazalone derivative formulations
05/27/2010US20100130574 Neurodegenerative diseases and methods of modeling
05/27/2010US20100130573 Treatment and prevention of deleterious effects associated with alcohol consumption
05/27/2010US20100130567 Medical agent for prevention or treatment of alzheimer 's disease
05/27/2010US20100130562 Stabilized Nicotine Chewing Gum
05/27/2010US20100130558 Novel substituted octahydrocyclopenta[c]pyrrol-4-amines as calcium channel blockers
05/27/2010US20100130554 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease
05/27/2010US20100130549 Psychotropic compounds, compositions and methods of use
05/27/2010US20100130547 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
05/27/2010US20100130546 Quinolone compound and pharmaceutical composition
05/27/2010US20100130540 Azaquinolinone derivatives and uses thereof
05/27/2010US20100130537 Cinnamide compounds for dementia
05/27/2010US20100130528 Adamantane modulators of nmda receptor and/or 5ht3 receptor
05/27/2010US20100130524 Therapeutic or prophylactic agent for dyskinesia
05/27/2010US20100130517 New 4,8-diphenyl-polyazanaphthalene derivatives
05/27/2010US20100130516 Purinyl derivatives and their use as potassium channel modulators
05/27/2010US20100130515 Polymorphs and solvates of a pharmaceutical and method of making
05/27/2010US20100130512 Fused-ring heterocycle opioids
05/27/2010US20100130510 Compounds for inflammation and immune-related uses
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130503 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
05/27/2010US20100130501 Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h, 6h) carbaldehyde derivatives
05/27/2010US20100130496 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
05/27/2010US20100130495 Compounds 563
05/27/2010US20100130487 Spiro-oxindole compounds and their uses as therapeutic agents
05/27/2010US20100130483 Novel diazabicyclic aryl derivatives
05/27/2010US20100130482 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
05/27/2010US20100130481 Anticonvulsant and anxiolytic methods of using receptor subtype selective agents
05/27/2010US20100130480 Benzoquinoline inhibitors of vesicular monoamine transporter 2
05/27/2010US20100130479 Gabaergic Agents to Treat Memory Deficits
05/27/2010US20100130478 Sustained release formulations of psychoactive drugs
05/27/2010US20100130477 Spirocyclobutyl Piperidine Derivatives
05/27/2010US20100130474 Alpha7 nicotinic acetylcholine receptor inhibitors
05/27/2010US20100130471 Renin Inhibitors
05/27/2010US20100130459 Neuroprotective 7-beta-hydroxysteroids
05/27/2010US20100130433 Casein-Derived Peptides having Anxiolytic Activity
05/27/2010US20100130432 Non-Natural Amino Acids and Neurotensin Analogues Thereof
05/27/2010US20100130431 Discordant helix stabilization for prevention of amyloid formation
05/27/2010US20100130425 Use of toll-like receptor ligands in treating excitotoxic injury, ischemia and/or hypoxia
05/27/2010US20100130410 Neural regeneration peptides and methods for their use
05/27/2010US20100129473 AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS
05/27/2010US20100129469 Use of dimiracetam in the treatment of chronic pain
05/27/2010US20100129444 Novel Pharmaceutical Formulations of Modafinil
05/27/2010US20100129443 Non-abusable pharmaceutical composition comprising opioids
05/27/2010US20100129441 Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
05/27/2010US20100129417 Dihydroxybenzoate Polymers and Uses Thereof
05/27/2010US20100129376 Osteopontin Specific Antibodies and Methods of Use Thereof
05/27/2010US20100129365 Treatment of inflammation using bst2 inhibitor
05/27/2010US20100129359 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
1 ... 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 ... 1833